ArticlePeerJ2026
Molecular characterization of
Article in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: The prevalence of extensively drug-resistant (XDR) and multidrug-resistant (MDR) strains worldwide has limited the ability of antimicrobial therapy to treat severe bacterial infections. The emergence and rapid global dissemination of carbapenemase-resistant Methods: CRKP isolates were tested for carbapenem resistance using the disc diffusion method. Molecular screening and identification of these isolates for carbapenemase genes and conducted molecular genotyping using Enterobacterial Repetitive Intergenic Consensus Polymerase Chain Reaction (ERIC-PCR) DNA fingerprinting to map clonal relatedness. Results: CRKP was identified in 112 clinical samples, all showing resistance to standard antimicrobials and at least one carbapenem. Molecular investigation of these CRKP isolates revealed a high epidemiological prevalence of Conclusion: This may indicate the attainment of an endemic state of the KPC genes, highlighting the need for an urgent establishment of stringent containment policies. These findings indicate the broad distribution of carbapenemase-producing
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.